1-10 of 10
Maria Victoria Mateos
Close
Sort by
Journal Articles

A research center’s experience of T-cell–redirecting therapies in triple-class refractory multiple myeloma

Borja Puertas, Adolfo Fernández-Sánchez, Elena Alejo, Beatriz Rey-Búa, Ana A. Martín-López, Estefanía Pérez-López, Miriam López-Parra, Lucía López-Corral, Norma C. Gutiérrez-Gutiérrez, Ramón García-Sanz, Noemi Puig, Verónica González-Calle, María-Victoria Mateos
Journal: Blood Advances
Blood Adv (2024) 8 (13): 3478–3487.
https://doi.org/10.1182/bloodadvances.2024012773
Published: 2024
Includes: Supplemental data
Journal Articles

Daratumumab for patients with myeloma with early or late relapse after initial therapy: subgroup analysis of CASTOR and POLLUX

Clinical Trials & Observations
Andrew Spencer, Philippe Moreau, Maria-Victoria Mateos, Hartmut Goldschmidt, Kenshi Suzuki, Mark-David Levin, Pieter Sonneveld, Robert Z. Orlowski, Sung-Soo Yoon, Saad Z. Usmani, Katja Weisel, Donna Reece, Tahamtan Ahmadi, Huiling Pei, Wendy Garvin Mayo, Xue Gai, Jodi Carey, J. Blake Bartlett, Robin Carson, Meletios A. Dimopoulos
Journal: Blood Advances
Blood Adv (2024) 8 (2): 388–398.
https://doi.org/10.1182/bloodadvances.2023010579
Published: 2024
Includes: Supplemental data
Journal Articles

Teclistamab impairs humoral immunity in patients with heavily pretreated myeloma: importance of immunoglobulin supplementation

Kristine A. Frerichs, Christie P. M. Verkleij, Maria Victoria Mateos, Thomas G. Martin, Cesar Rodriguez, Ajay Nooka, Arnob Banerjee, Katherine Chastain, Alfredo Perales-Puchalt, Tara Stephenson, Clarissa Uhlar, Rachel Kobos, Bronno van der Holt, Sandy Kruyswijk, Maria T. Kuipers, Kaz Groen, Deeksha Vishwamitra, Sheri Skerget, Diana Cortes-Selva, Margaret Doyle, Hans L. Zaaijer, Sonja Zweegman, Raluca I. Verona, Niels W. C. J. van de Donk
Journal: Blood Advances
Blood Adv (2023) 8 (1): 194–206.
https://doi.org/10.1182/bloodadvances.2023011658
Published: 2023
Includes: Supplemental data
Journal Articles

Final analysis of carfilzomib, dexamethasone, and daratumumab vs carfilzomib and dexamethasone in the CANDOR study

Clinical Trials & Observations
Saad Z. Usmani, Hang Quach, Maria-Victoria Mateos, Ola Landgren, Xavier Leleu, David Siegel, Katja Weisel, Xiaomei Shu, Chuang Li, Meletios Dimopoulos
Journal: Blood Advances
Blood Adv (2023) 7 (14): 3739–3748.
https://doi.org/10.1182/bloodadvances.2023010026
Published: 2023
Includes: Supplemental data
Journal Articles

Mass spectrometry vs immunofixation for treatment monitoring in multiple myeloma

Noemí Puig, María-Teresa Contreras, Cristina Agulló, Joaquín Martínez-López, Albert Oriol, María-Jesús Blanchard, Rafael Ríos, Jesús Martín, María-Belén Iñigo, Anna Sureda, Miguel-Teodoro Hernández, Javier de la Rubia, Verónica González-Calle, Isabel Krsnik, Valentín Cabañas, Luis Palomera, José-María Moraleda, Joan Bargay, María-Teresa Cedena, Bruno Paiva, Laura Rosiñol, Joan Bladé, Jesús San Miguel, Juan-José Lahuerta, María-Victoria Mateos
Journal: Blood Advances
Blood Adv (2022) 6 (11): 3234–3239.
https://doi.org/10.1182/bloodadvances.2021006762
Published: 2022
Includes: Supplemental data
Journal Articles

FlowCT for the analysis of large immunophenotypic data sets and biomarker discovery in cancer immunology

Cirino Botta, Catarina Maia, Juan-José Garcés, Rosalinda Termini, Cristina Perez, Irene Manrique, Leire Burgos, Aintzane Zabaleta, Diego Alignani, Sarai Sarvide, Juana Merino, Noemi Puig, María-Teresa Cedena, Marco Rossi, Pierfrancesco Tassone, Massimo Gentile, Pierpaolo Correale, Ivan Borrello, Evangelos Terpos, Tomas Jelinek, Artur Paiva, Aldo Roccaro, Hartmut Goldschmidt, Hervé Avet-Loiseau, Laura Rosinol, Maria-Victoria Mateos, Joaquin Martinez-Lopez, Juan-José Lahuerta, Joan Bladé, Jesús F. San-Miguel, Bruno Paiva,
Journal: Blood Advances
Blood Adv (2022) 6 (2): 690–703.
https://doi.org/10.1182/bloodadvances.2021005198
Published: 2022
Includes: Supplemental data
Journal Articles

Early detection of treatment failure and early rescue intervention in multiple myeloma: time for new approaches

Clinical Trials & Observations
Juan José Lahuerta, Bruno Paiva, Ana Jiménez de Ubieto, José Sánchez-Pina, María-Victoria Mateos, Joan Bladé, Jesús F. San-Miguel
Journal: Blood Advances
Blood Adv (2021) 5 (5): 1340–1343.
https://doi.org/10.1182/bloodadvances.2020003996
Published: 2021
Journal Articles

Quantitative expression of Ikaros, IRF4, and PSMD10 proteins predicts survival in VRD-treated patients with multiple myeloma

Clinical Trials & Observations
Irena Misiewicz-Krzeminska, Cristina de Ramón, Luis A. Corchete, Patryk Krzeminski, Elizabeta A. Rojas, Isabel Isidro, Ramón García-Sanz, Joaquín Martínez-López, Albert Oriol, Joan Bladé, Juan-José Lahuerta, Jesús San Miguel, Laura Rosiñol, María-Victoria Mateos, Norma C. Gutiérrez
Journal: Blood Advances
Blood Adv (2020) 4 (23): 6023–6033.
https://doi.org/10.1182/bloodadvances.2020002711
Published: 2020
Includes: Supplemental data
Journal Articles

Efficacy and safety of carfilzomib-based regimens in frail patients with relapsed and/or refractory multiple myeloma

Clinical Trials & Observations
Thierry Facon, Ruben Niesvizky, Maria-Victoria Mateos, David Siegel, Cara Rosenbaum, Sara Bringhen, Katja Weisel, P. Joy Ho, Heinz Ludwig, Shaji Kumar, Kenneth Wang, Mihaela Obreja, Zhao Yang, Zandra Klippel, Khalid Mezzi, Amanda Goldrick, Christina Tekle, Meletios A. Dimopoulos
Journal: Blood Advances
Blood Adv (2020) 4 (21): 5449–5459.
https://doi.org/10.1182/bloodadvances.2020001965
Published: 2020
Includes: Supplemental data
Journal Articles

Timing of treatment of smoldering myeloma: early treatment

Clinical Trials & Observations
María-Victoria Mateos, Verónica González-Calle
Journal: Blood Advances
Blood Adv (2018) 2 (21): 3045–3049.
https://doi.org/10.1182/bloodadvances.2018021220
Published: 2018